Wednesday, 21 February 2024


Lonza enriches its Cell-Culture techniques with Quasi Vivo System

13 February 2018 | News

This new product offering from Lonza is a result of a worldwide marketing and distribution agreement with Kirkstall

Lonza announced the latest addition to its cell-culture product portfolio with the Quasi Vivo® System.

The Quasi Vivo® Device consists of an advanced, interconnected fluidics system to create more physiologically relevant cell-culture conditions, helping researchers improve the predictive value of their studies. 

This new product offering from Lonza is a result of a worldwide marketing and distribution agreement with Kirkstall (a biotechnology company based in Rotherham, UK). 

Kirkstall developed the Quasi Vivo® System, which consists of interconnected cell-culture chambers and a peristaltic pump to create a continuous flow of media over cells.

As a result, cultures are exposed to more physiologically relevant conditions, increasing the predictive value of in vitro experiments. 

The Quasi Vivo® System is available with three different culture chambers (QV500, QV600, and QV900) to support a wide range of applications, including submerged cell culture, co-culture and modeling of air-liquid and liquid-liquid interfaces.

Not only is the Quasi Vivo® System easy to set up, it also enables close monitoring of variables during an experiment.

Furthermore, the large scale and user configurability of the Quasi Vivo® System allows assays to be performed that are not possible using microfluidic systems.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account